"The SarsCoV2 virus is mutating at breakneck speed and continues to do so, now we will see what the step will be, but we must expect that there will still be several mutations in the coming months. We are actually coming out of the pandemic but the virus is still unpredictable."
This was stated by
Marco Cavaleri
, head of vaccines and Covid therapeutic products of the European Medicines Agency (
Ema
), at the meeting 'Efficacy and safety of new bivalent vaccines' organized by Unamsi.
"We all want to be optimistic and we have built an ever-increasing immunity in the population, but in view of the Autumn we need more prudence".
"We hope - said Cavaleri - that soon this virus will reach the right balance to be able to live with men as for flu viruses, because then we will be able to better predict how to change the composition of vaccines for better vaccination campaigns".
Compared to the adapted vaccines against Omicron, "what we want to see with these new adapted vaccines is that the protection lasts longer, and that the new vaccination can be done after 8 months; this is the expectation," he stressed.
Cavaleri therefore reiterated that those who have been naturally exposed to the virus during the Omicron period can wait 3-4 months before the further recall.
Furthermore, in reference to the so-called 'Indian' variant Omicron BA.2.75, "could take over,
